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Abstract
Identifying transcription factor binding sites genome-wide using chromatin immunoprecipitation (ChIP)-based technology
is becoming an increasingly important tool in addressing developmental questions. However, technical problems associated
with factor abundance and suitable ChIP reagents are common obstacles to these studies in many biological systems. We
have used two completely different, widely applicable methods to determine by ChIP the genome-wide binding sites of the
master myogenic regulatory transcription factor HLH-1 (CeMyoD) in C. elegans embryos. The two approaches, ChIP-seq and
ChIP-chip, yield strongly overlapping results revealing that HLH-1 preferentially binds to promoter regions of genes
enriched for E-box sequences (CANNTG), known binding sites for this well-studied class of transcription factors. HLH-1
binding sites were enriched upstream of genes known to be expressed in muscle, consistent with its role as a direct
transcriptional regulator. HLH-1 binding was also detected at numerous sites unassociated with muscle gene expression, as
has been previously described for its mouse homolog MyoD. These binding sites may reflect several additional functions for
HLH-1, including its interactions with one or more co-factors to activate (or repress) gene expression or a role in chromatin
organization distinct from direct transcriptional regulation of target genes. Our results also provide a comparison of ChIP
methodologies that can overcome limitations commonly encountered in these types of studies while highlighting the
complications of assigning in vivo functions to identified target sites.
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Introduction
Chromatin immunoprecipitation (ChIP) is becoming an increas-
ingly popular means to survey the genome-wide distribution of
chromatin-associated proteins and their post-translational modifi-
cations. This approach is challenging when applied to many
transcription factors because they are often present at low levels
withincells and arelocated discretely, and ofteninfrequently,within
chromatin. These problems are amplified in complex tissues if the
transcription factor is expressed in only a subset of the cell types
within the tissue/organism or is temporally restricted. In addition,
many transcription factorslackspecific antibodies suitable for ChIP,
leaving researchers to opt for indirect methods to interrogate
chromatin-associated binding site for the factor of interest.
To address these issues, we have compared two completely
different ChIP methods to determine the genome-wide distribu-
tion of HLH-1 (sometimes referred to as CeMyoD) binding sites in
C. elegans mixed stage embryos. One method utilized vast over-
production of HLH-1 from a heat shock inducible transgene,
immunoprecipitation with an anti-HLH-1 antibody, and hybrid-
ization to a genome tiling array (ChIP-chip). The second method
employed a Green Fluorescent Protein (GFP)-tagged, low copy
number, integrated hlh-1 translational fusion transgene, immuno-
precipitation with an anti-GFP antibody, and next-generation
sequencing (ChIP-seq). The advantage of over expression is that it
can overcome limitations in transcription factor abundance and
antibody affinity. The obvious disadvantage of over expression is
the potential for ectopic binding to result in misleading profiles of
the genome wide distribution. This latter concern may also be
applicable to certain epitope-tagged transgenes, although likely less
problematic when expression is directed by sequences representing
the natural genomic context for the gene of interest that are
integrated as one or a few copies. In fact, early results from GFP-
tagged coding regions using bacterial recombineering in fosmid
clones look very promising in terms of recapitulating endogenous
patterns of transcription factor expression and binding [1,2]. We
reasoned that the use of two very different approaches to
determine the genome-wide HLH-1 binding sites would allow us
to cross validate the data from each while exploring techniques
that could be used to overcome limitations that will be commonly
encountered in the study of transcription factor binding sites by
ChIP.
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15898The results from each experimental approach were remarkably
similar and suggested that there are a large number of HLH-1
binding sites genome-wide, primarily located in promoter regions
of candidate target genes. Analysis of these HLH-1-positive ChIP
genomic fragments demonstrated that E-box (CANNTG) se-
quences, known binding sites for HLH-1 and related helix-loop-
helix factors, are the predominantly over-represented motif. We
have validated our HLH-1 candidate binding sites by ChIP-
qPCR, comparisons to independently derived ChIP data, and by
reporter gene expression. This analysis demonstrates that both
over expression and epitope-tagging of transcription factors can
provide a valid profile of DNA binding sites throughout the
genome. Moreover, our results highlight the difficulty in ascribing
biological functions to ChIP-defined binding sites, a problem
common to all current approaches.
Results
Striated muscle cell fate specification and differentiation in
animals is orchestrated at the transcriptional level by Myogenic
Regulatory Factors (MRFs) [3,4]. HLH-1 is the lone MRF
homolog in C. elegans and it functions together with other
transcription factors to specify bodywall muscle fate and direct
differentiation [5,6]. It is generally assumed that HLH-1 directly
activates muscle-specific gene expression, just as MRFs act as
transcriptional activators of muscle genes in higher eucaryotes. In
vitro, HLH-1 binds the canonical basic helix-loop-helix DNA site
known as an E-box (CANNTG). However, this simple sequence is
present frequently throughout the genome (291,374 sites in C.
elegans), requiring additional experimental evidence to directly link
HLH-1 to downstream target gene activation. Chromatin
immunoprecipitation (ChIP), coupled with either whole genome
tiling arrays (ChIP-chip) or high throughput sequencing (ChIP-
seq), offers the potential to make this link and to provide insight
into the molecular mechanisms and logic underlying myogenesis
and other differentiation programs.
Polyclonal antibodies have been prepared against full-length
HLH-1 fusion proteins in chickens. Previous attempts to use this
antibody in chromatin immunoprecipitation experiments in wild
type animals to assay binding to cis-acting hlh-1 enhancer
fragments known to be involved in positive auto-regulation were
unsuccessful [7]. We also failed to detect HLH-1 binding to
autoregulatory enhancer sequences in strains harboring high copy
number hlh-1 reporter transgenes. The inability to ChIP
endogenous levels of HLH-1 reflects a problem likely to be
common for transcription factor studies in many model systems,
leading us to explore alternative approaches to profile HLH-1
binding sites on a genomic scale. HLH-1 is an excellent test case
for this approach because muscle gene expression has been well
documented in C. elegans, providing a predictable set of target
genes that should be identified by ChIP if HLH-1 function is direct
and restricted to bodywall muscle genes.
HLH-1 binds to the promoter region of 1,000s of
potential target genes
We have previously described an integrated transgene express-
ing a full-length hlh-1 cDNA from a heat shock promoter [7]. Heat
shock induction of HLH-1 during early embryogenesis results in
high levels of nuclear-localized protein and widespread conversion
of blastomeres to the bodywall muscle fate, demonstrating this
over expressed factor is functional and can activate target genes in
muscle. We have used this strain to over express HLH-1 in mixed
stage embryos that were collected three hours post-induction for
ChIP using an anti-HLH-1 antibody raised in chickens (see
Materials & Methods). ChIP-enriched DNA sequences were
amplified and hybridized to high-density DNA tiling arrays
spanning the entire C. elegans genome (Nimblegen) with a probe
length of 50 bp, centered 36 bp apart. Regions of HLH-1 genomic
binding were determined using CARPET [8] and annotated to the
nearest transcriptional start site (TSS).
HLH-1 ChIP-chip data from mixed stage embryo populations
was collected from three independent, biological replicates. The
data was normalized using the Bi-weight and Mean Summariza-
tion functions in CARPET [8] revealing correlation coefficients
between 0.71 and 0.78 for all replicate comparisons. We found
1,376 HLH-1 bound peaks genome wide (Table S1) with bound
interval sequences averaging 1,454 bp in length. The majority of
HLH-1 peaks (82%) were located in the promoter or intragenic
regions relative to protein coding genes; the remaining peaks
(18%) were located in more distal regions (.2 Kb from the TSS).
The distribution of HLH-1 bound intervals relative to the TSS
revealed the 2200 to 2400 bp region as the most frequent
location of binding sites (Figure 1) and identified 1,032, of the
predicted ,20,000 (WS195) protein encoding genes, as potential
targets of HLH-1 regulation (Table S2).
As part of the modENCODE pipeline, a GFP-tagged hlh-1
translational fusion transgene was generated by recombineering as
previously described [1,2]. This transgene was integrated into the
genome in low copy number by particle bombardment using a
standardized modENCODE protocol for targeted transcription
factors that aims to reflect the natural temporal and spatial pattern
of expression for the factor of interest with expression at, or near,
wild type levels. Mixed staged, transgenic embryos were isolated
for chromatin preparation from two biological replicates and
subjected to ChIP-seq as previously described [1].
Using the CARPET package [8] to analyze modENCODE
ChIP-seq data,wefound 20,143 peaks ofHLH-1bindingassociated
with 10,037 candidate genes. Because this analysis linked HLH-1 to
nearlyhalfofallknownproteincodinggenesinC.elegans,weapplied
increasingly stringent thresholds for peak calls (using p-values) to
further restrict the genes used for our analysis (Figure 2A). At a p-
value cutoff between 10
25 and 10
26, we noted an inflection point in
the data where the peak and gene values for the two ChIP datasets
transitioned from a non-linear to a near linear relationship.
Similarly, the overlaps between ChIP-seq gene calls and previously
reported bodywall muscle expressed genes (described below) were
near linear at cutoff values between 10
25 and 10
210. This suggested
that at stringencies between 10
26 and 10
210, the reduction in peaks
and genes identified was reflecting a simple truncation of the
number of calls rather than increasing, biologically relevant
discrimination. Thus, we chose a conservative cutoff peak p-value
at 10
26 for all subsequent analysis of the ChIP-seq data, resulting in
4,016 peaks associated with 2,753 unique candidate target genes
(Tables S2 & S3) with an average peak interval length of 534 bp.
The distribution of peak location relative to the TSS for this set of
genes is shown in Figure 1. As with the HLH-1 ChIP-chip data, the
most frequent location of the HLH-1 ChIP-seq peaks (10
26 cutoff)
was just upstream of the TSS. Data from either method had a
distribution that fell off steeply upstream of the TSS, but remained
elevated above background downstream of the TSS, extending
nearly 6 Kb.
We employed the CARPET package [8] Com&Easy function
and Galaxy [9] to further compare the overlap of peak calls
between HLH-1 ChIP datasets (see Materials and Methods). Of
the 1,376 peaks identified after heat shock induction of HLH-1,
59% overlapped with the ChIP-seq peak calls (10
26 cutoff)
(Figure 2B.). Software developed by Lund and colleagues (http://
elegans.uky.edu/MA/progs/Compare.html) was used to compare
Genome Wide CeMyoD Binding Sites by ChIP
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approach. Comparison of gene lists revealed that 569 of the 1,032
(55%) candidate genes associated with ChIP-chip were present in
the ChIP-seq (10
26 cutoff) list of 2,753 genes (Figure 2B, Table
S2); the overlap increased to 862 (84%) genes for the default ChIP-
seq data. Visual inspection of the heat shock versus transgene
HLH-1 ChIP datasets in the Integrated Genome Browser (IGB)
confirmed substantial overlap of the patterns (Figure S1). We
noted that the 10
26 ChIP-seq data failed to identify many ChIP-
chip genes (45%), a result that likely reflects not only the more
stringent cutoff threshold, but also several technical differences
between the methods. For example, the two ChIP methods used
different antibodies for immunoprecipitation (chicken anti-HLH
versus donkey anti-GFP) that likely cross-react differently with
chromatin proteins resulting in very different non-specific
background binding sites. However, the HLH-1 binding sites
common to these two very different methods suggest that many
(55–84%) of the gene calls reflected bona fide regions of HLH-1
localization in embryonic chromatin.
HLH-1 ChIP peaks validate in vitro
Previous ChIP studies have characterized HLH-1 bound
enhancer regions regulating hlh-1, providing a very limited, yet
important, internal control set of sites for comparisons to our most
recent data. HLH-1 positive auto-regulation of its own expression
occurs through several enhancer elements located upstream of the
coding region and within the first large intron of hlh-1 [7].
Comparison of both the ChIP-chip and ChIP-seq (10
26) HLH-1
data to these known sites demonstrates that all four previously
described HLH-1 bound enhancers were detected by both
genome-wide approaches (Figure 3), with the ChIP-seq data
suggesting that additional HLH-1 binding sites may extend further
upstream of the gene than previously appreciated. A second
previously characterized HLH-1 binding site upstream of the gene
unc-120 failed to be detected by ChIP-chip, but was detected by
ChIP-seq using 10
26 thresholding (data not shown).
Quantitative PCR (qPCR) was used to confirm HLH-1 bound
regions determined by either ChIP-chip or ChIP-seq methods. For
the HLH-1 ChIP-chip peak calls, we generated qPCR amplicons
to interrogate 20 regions ranked in the top 300 by peak score, 10
peaks ranked in the middle between 301–800, and 10 peaks
ranking at the bottom between 801–1,376. As shown in Figure 4,
results from two separate HLH-1 ChIP-qPCR experiments
confirmed the ChIP-chip results for 20/20 top-ranked peaks
(Figure 4A), 9/10 middle-ranked peaks, and 8/10 low-ranked
peaks (Figure 4B). Taken together, the ChIP qPCR results
confirmed 93% of sampled peaks identified by ChIP-chip. Of
the 40 ChIP-chip amplicons assayed, 20 (50%) corresponded to
ChIP-seq peaks (Figure 4A & B, black numbers); all 20 were
positive by qPCR, confirming these HLH-1 binding sites by three
independent methods. As negative controls for ChIP-qPCR, we
used a region from the hlh-1 promoter previously shown to be
unable to preferentially bind HLH-1 [7] (Figure 4) and amplicons
upstream of genes previously identified as being expressed and/or
enriched in germ line [10], hypodermis (http://tock.bcgsc.bc.ca/
cgi-bin/sage140), or gut [11,12,13]. HLH-1 ChIP-qPCR demon-
strated binding slightly above background for only one of these 31
negative control amplicons (Figure 4C). These results suggested
that the vast majority of HLH-1 bound intervals detected in
embryonic chromatin by array hybridizations are factor-specific
and are reproducibly detected by deep sequencing or qPCR, with
the confidence of detection directly related to the peak score.
As noted above, the ChIP-seq (10
26) data revealed a number of
peaks that were not present in the ChIP-chip data. To determine if
these potential sites of HLH-1 binding were valid, we assayed 20
amplicons from ChIP-seq peaks with scores from the top 1,000 as
Figure 1. The distribution of HLH-1 ChIP peaks relative to the transcriptional start site (TSS) of protein coding genes. The density of
peaks (10
24) located within 2 kb upstream or 6 kb downstream of defined TSS (WS195) were binned in sets of 200 bp, averaged and the value
plotted. Similar distributions of HLH-1 binding sites were observed for both ChIP-chip (dashed) and ChIP-seq (solid) datasets. Maximal clustering of
binding sites was observed in the 2200 to 2400 bp bins with a sharp decline upstream of the gene and gradual decline throughout the region
downstream of the TSS.
doi:10.1371/journal.pone.0015898.g001
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bottom ranks. As shown in Figure 4D & E, all but one of the 20
top peaks validated as did 80% of the peaks from the middle or
bottom ranked lists. Importantly, the method used to validate the
ChIP-seq data was immunoprecipitation with anti-HLH-1 anti-
bodies from mixed stage embryos over expressing the HLH-1, that
is, our ChIP-chip protocol. We concluded that the vast majority of
ChIP-seq peaks (10
26) were valid sites of HLH-1 binding and that
our ChIP-chip data under-represented these sites.
HLH-1 ChIP bound intervals contain E-Box sequence
motifs and are enriched for muscle expression
To determine if HLH-1 bound peaks identified by our two
different ChIP methods contained over represented motifs, DNA
sequences corresponding to HLH-1-bound genomic intervals were
analyzed using MDscan [14]. Analysis of the sequences from the
top 40 peak scores from HLH-1 ChIP-chip revealed E-Box
sequences (CANNTG) as the primary over represented sequence
motif when the width interval was set to either six or eight
nucleotides; 7 of the top 10 motifs were E-boxes (Figure 5A). The
same was true for the top 40 HLH-1 ChIP-seq peaks. In fact, E-
Box sequences continued to be a top motif returned by MDscan
analysis for peak scores extending to include the top 370 out of
1,376 HLH-1 ChIP-chip or top 120 out of 4,016 HLH-1 ChIP-seq
intervals analyzed. The only other recurrent motif to emerge from
the top ChIP binding sites was CACNCA (an its compliment), a
motif common to many promoter regions (M. Krause, unpub-
lished), and present in both the ChIP-chip and ChIP-seq datasets.
While E-boxes are a known consensus basic helix-loop-helix
transcription factor binding motif and HLH-1 binds these
sequences promiscuously in vitro [15,16,17], only a small subset
of all possible E-boxes genome wide were identified by ChIP. Of
the 291,374 E-box sequences present in the C. elegans genome, only
10,082 (3.5%) were identified after over expression of HLH-1 in
our ChIP-chip experiments. Similarly, only 10,543 (3.6%) E-box
sites were identified by ChIP-seq (10
26), a number that rises to
24,061 (8.3%) in the unabated, default ChIP-seq data. We
concluded from this data that there is a high degree of selectivity
for HLH-1 binding that restricts it to only a small fraction of the
potential E-box sites present in the genome.
Gene Ontology (GO) analysis in GENECODIS [18,19] and
DAVID Bioinformatics Resources 6.7 [20,21] was used to
determine biological processes enriched in the candidate HLH-1
target gene lists. Enriched GO terms for the HLH-1 ChIP-chip
peaks included embryonic development, larval development,
reproduction, regulation of growth rate, locomotion, growth,
and body morphogenesis (Figure 5B), consistent with the role of
HLH-1 in embryonic development and bodywall myogenesis.
Inspection of genes identified with unexpected GO terms, such as
oviposition or hermaphrodite genitalia development, revealed they
Figure 2. The overlap of HLH-1 ChIP peak and gene calls. A) Peaks, or genes associated with peaks, from ChIP-seq data using the default
modENCODE thresholds were used to normalize the overlapping number of peaks or genes in the ChIP-chip data. The percent overlap in peak or
gene lists between the ChIP-chip data compared to the ChIP-seq data at default settings or at increasing peak call stringency using p-values for the
ChIP-seq data is plotted. The peak and gene numbers associated with the 10
26 threshold (arrow) was chosen as a more stringent cutoff for
subsequent analysis. B) Proportional area Venn diagrams showing the overlap of peak (left) or gene (right) calls from the ChIP-seq (10
26 threshold)
compared to the ChIP-chip data.
doi:10.1371/journal.pone.0015898.g002
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mental processes, including cell division, cell migration, vesicular
trafficking, and chromatin reorganization. The GO analysis of the
HLH-1 ChIP-seq candidate target gene list was nearly identical,
including the rank order of the relative processes that were
enriched. A random set of 3,000 genes failed return the same
processes when subjected to an identical GO analysis, suggesting
HLH-1 candidate target genes identified by either approach were
factor-, and not method-, specific.
If HLH-1 is involved in the direct activation of genes expressed
in bodywall muscle, there should be a correlation between the
HLH-1 target genes identified by ChIP and the bodywall muscle
transcriptome. Several groups, using a variety of techniques and
approaches, have profiled bodywall muscle gene expression in C.
elegans. Examples include 1,064 genes enriched in bodywall
muscles of L1 larvae using polyA binding protein tagging [22],
and genes expressed in embryonic bodywall muscle based on
reporter gene sorted blastomeres analyzed by microarray tech-
niques [23] or SAGE [24]. We have also previously profiled the
temporal pattern of genome wide expression in response to the
heat shock induced hlh-1 transgene used for ChIP-chip in this
study [5,6]; taking genes identified as up-regulated by hlh-1 over
expression 6 hours after induction resulted in a list of 927 genes.
Finally, a compilation of community data at WormAtlas (http://
www.wormatlas.org) was used to generate a list of 480 genes
expressed in bodywall muscle that was further culled of genes also
expressed in the hypodermis to yield a more tissue restricted list of
297 bodywall muscle genes.
We compared our HLH-1 ChIP-chip and ChIP-seq candidate
target gene lists with each of these previously identified bodywall
muscle gene lists, normalizing to the number of genes in each list.
As controls for these comparisons, we used three randomly
generated sets of 2,000 genes each using an alphabetical sort of all
genes from WormBase (WS195) data http://www.wormbase.org
as well as lists of genes previously described as enriched in the
adult germline (1,063 genes)[10], oogenesis (1,030 genes) [25], or
embryonic intestine (80 genes) [12]. As shown in Figure 6,
previously identified bodywall muscle enriched/expressed gene
lists were over-represented in our ChIP data, with similar results
for both HLH-1 ChIP-chip and ChIP-seq experiments. As
expected, the most highly expressed genes in bodywall muscle,
as assayed by muscle cell sorting and SAGE tag counts (top 100),
were the most enriched in the ChIP data (Figure 6). Note that for
these genes, the overlap of ChIP-chip and ChIP-seq data was also
the highest, demonstrating that validation by the two independent
ChIP methods provides higher confidence of bodywall muscle
expression. For two of the bodywall muscle gene lists, the ChIP-
seq data was significantly enriched whereas the ChIP-chip data
was close to background. Each of these two muscle gene
expression lists was derived from manipulated embryos assayed
by expression microarrays. It is not obvious why such assays would
result in the strong bias towards under-representation in the ChIP-
chip data, although those experiments were looking at early onset,
rather than persistent, expression in bodywall muscle. Among the
control gene lists, one of the three random lists was slightly
enriched in the ChIP data whereas the other two, along with the
germline-related lists and the embryonic intestine list, were at
background levels. We concluded that both experimental
approaches to identify HLH-1 binding sites by ChIP resulted in
associated candidate target genes that were enriched for either
suspected or known bodywall muscle genes, suggesting HLH-1
activation of these targets is direct. We cannot exclude the
Figure 3. Visualization of HLH-1 ChIP data at the hlh-1 locus. The hlh-1 gene positively autoregulates its own expression through several
previously defined enhancers located upstream and within the first intron of the gene [7]. An Integrated Genome Browser (IGB) view of the ChIP data
centered on the hlh-1 locus on LGII of C. elegans shows the peak intervals at top (blue boxes) relative to gene coding regions on the plus and minus
coding strands below (green boxes). ChIP-seq intervals using both default and 10
26 thresholds are shown for comparison to the ChIP-chip intervals;
both approaches identify previously defined HLH-1 binding sites (*) involved in autoregulation. The ChIP-seq data suggest additional binding sites
might exist (?) further upstream and downstream of the hlh-1 gene.
doi:10.1371/journal.pone.0015898.g003
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PLoS ONE | www.plosone.org 5 December 2010 | Volume 5 | Issue 12 | e15898Figure 4. Quantitative PCR validation of ChIP data. (A, B) ChIP-chip peak validation. Amplicons corresponding to HLH-1 ChIP-chip peaks
ranked at the top (A; 1–20), middle (B; 21–30) or bottom (B; 31–40) of the list were selected for validation. These amplicons were tested in a minimum
of two independent ChIP-qPCR experiments each for enrichment with HLH-1 antibody (blue) over pre-immune serum (purple). Using a validation
threshold of greater than 2-fold enrichment over pre-immune serum alone (dotted line), 37/40 amplicons validated by qPCR whereas a negative
control region (Neg) did not. Of the 40 ChIP-chip amplicons tested, 20 also corresponded to ChIP-seq peak calls (A & B black numbers); all 20 of these
validated by ChIP-qPCR. (C) For each of 10 genes previously described as expressed in the germline, hypodermis, or intestinal cells, amplicons were
chosen from the putative promoter regions upstream of the TSS. These 30 amplicons, along with the hlh-1 gene negative control regions, were
assayed for enrichment after HLH-1 ChIP (blue) relative to pre-immune serum (purple). Only one of the 30 negative controls crossed the validation
threshold of 2-fold enrichment over background. (D, E) ChIP-seq peak validation. Amplicons corresponding to HLH-1 ChIP-seq peaks not detected by
ChIP-chip and ranked at the top (D; 1–20), middle (E; 21–30) or bottom (E; 31–40) of the list were selected for validation. From the top ranked peak
amplicons, 19/20 validated, as did 8/10 for each of lower ranked peaks. Amplicon information, primer sequences, and additional negative controls are
given in Table S4.
doi:10.1371/journal.pone.0015898.g004
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transcription in other somatic tissues.
Previous studies have suggested that the distribution of bodywall
muscle genes throughout the genome is non-random, with
evidence for clustering and under-representation of muscle genes
on certain linkage groups, including the X chromosome [22]. We
analyzed the chromosomal distribution of potential HLH-1 target
genes identified by ChIP and found that the X chromosome had
an over-, not under-, representation of such genes, with 13–18% of
genes on autosomes versus 21–29% on the X chromosome.
Restricting the analysis to only the 569 genes identified both by
ChIP-chip and ChIP-seq, the X chromosome contained 34% of
the genes, chromosomes I and V having a low of only 9–10%, and
the remaining autosomes ranging between 14–17%. Inspection of
the X-linked genes revealed no obvious pattern in distribution or
over-represented process by GO analysis.
HLH-1 ChIP interval validation in vivo is problematic
In order to assay the potential biological relevance of the HLH-
1 binding sites identified by ChIP, we generated GFP reporter
genes by placing HLH-1 bound interval sequences upstream of a
myo-2::gfp minimal promoter. We, and others, have used the myo-
2::gfp minimal promoter (Fire vector L3136) in the past as a robust
assay for bodywall-specific transcriptional enhancer activity for test
sequences [7,26]. We selected 20 positive peak intervals identified
by HLH-1 ChIP-chip, 17 of which overlapped with ChIP-seq
called peaks. As shown in Table 1, these intervals were heavily
biased towards association with known bodywall muscle expressed
genes (18/20), varied in length between 350 and 2,333 bp and,
with one exception, contained multiple E-box sequences. Surpris-
ingly, only 6 of these 20 intervals (associated with the genes
T28B11.1, cye-1, etr-1, let-60, unc-60, and ric-3) were positive for
bodywall muscle enhancer activity when introduced as stable
extrachromosomal transgenes in an otherwise wild type back-
ground (Table 1; Figure S2). These six positive fragments had a
wide range of E-boxes (4–13), were all detected by both ChIP-chip
and ChIP-seq approaches, and had elevated peak scores with a
value of 4.6 or greater in the HLH-1 ChIP-chip data.
Interestingly, 12 of the 14 intervals that failed to direct bodywall
muscle expression of the reporter gene were associated with genes
known to be expressed in bodywall muscle. That is, the associated
gene was expressed in bodywall muscle, however, the ChIP
identified HLH-1 binding site interval was not sufficient by itself to
drive expression of an enhancer test reporter gene in those cells.
We concluded that no single metric associated with an HLH-1
positive interval reliably predicted in vivo bodywall muscle
enhancer activity, although active intervals usually had higher
peak scores, contained multiple E-box elements, and were detected
by both ChIP-chip and ChIP-seq approaches.
It was possible that the failure of HLH-1 bound intervals to
enhance bodywall muscle reporter gene expression in wild type
animals was due to the relatively low levels of endogenous HLH-1
compared to the levels of heat shock induced HLH-1 or epitope-
tagged HLH-1 used to identify potential binding sites by ChIP. To
Figure 5. Over represented motifs and GO terms in HLH-1 ChIP data. A) Genomic sequences corresponding to the top 40 peaks of HLH-1
binding by either ChIP-chip or ChIP-seq (10
26 threshold) were analyzed for over represented motifs using MDscan and LOGO software (http://
weblogo.berkeley.edu/logo.cgi). Shown are five representatives LOGOs of the top 10 sequence motifs returned for each dataset using a window
width of six base pairs. An E-box (CANNTG; marked (E)), the preferred HLH-1 binding site, is a frequent hit (7/10) among the top motifs identified,
regardless of ChIP method. The simple repeat CACACA (and its compliment) is also returned and has been previously associated with PHA-4 bound
promoter sequences [1]. B) Gene Ontology (GO) analysis of genes identified by HLH-1 ChIP. The top 20 Biological Process (BP) GO term hits for the
1,032 genes identified by HLH-1 ChIP-chip are shown in rank order. Seventeen of the 20 GO BP terms were also returned by a similar analysis of the
2,753 genes identified by HLH-1 ChIP-seq (10
26 threshold) with nearly identical rank order. Most terms are consistent with embryonic growth and
muscle development, including the terms oviposition and hermaphrodite genitalia development that include many genes common to general
processes active in embryogenesis.
doi:10.1371/journal.pone.0015898.g005
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enhancer assay reporter constructs into a strain harboring the heat
shock promoter driven HLH-1 transgene and assayed bodywall
muscle enhancer activity with and without heat shock induction of
HLH-1. The seven reporters tested included five that failed in the
original enhancer assay in a wild type background (emb-9, unc-112,
ceh-20, aqp-2, unc-73) and two that were positive for expression in
wild type animals (etr-1, ric-3). All seven reporter constructs were
injected, along with a rescuing unc-119 plasmid, into the hsp::hlh-1,
unc-119 stain and non-Unc animals selected for the assay. None of
the seven reporters showed a strong or reproducible response to
heat shock induced HLH-1 when assayed at multiple times after
induction in embryos, larvae, or adults (Table 1). To confirm that
the heat shock promoter driving the cDNA encoding HLH-1 was
still active in these strains, we assayed by Western blot the level of
HLH-1 protein before and after heat shock in mixed stage
embryos. All stains strongly induced HLH-1 to high levels within
3 hours after induction, as previously reported (Figure S3) [7]. We
concluded that the ability of a genomic interval to bind HLH-1 by
ChIP analysis was a poor metric for ascribing biological activity in
vivo for the interval functioning out of its normal genomic context.
This is particularly evident from the failure of heat shock induced
HLH-1 to activate any of the enhancer reporter genes; this
enhancer reporter resulted in strong, widespread, ectopic activity
Figure 6. Comparison of ChIP-associated genes and bodywall muscle transcription. (Top) Bodywall muscle gene enrichment. Lists of peak-
associated genes identified by HLH-1 ChIP-chip, ChIP-seq, or the overlap of both ChIPs were compared with lists of genes thought to be expressed
and/or enriched in bodywall muscle cells during embryonic and/or post-embryonic development from previous studies (see text). As controls, lists for
genes expressed in intestinal (Int), germline and oogenesis, as well as three random gene lists (see text), were also compared to the ChIP data. The
fold enrichment for these comparisons relative to theoretical randomization (value of 1.0) is plotted for each list with the number of genes in each list
noted parenthetically. The ChIP data (regardless of method) was significantly enriched for genes expressed and/or enriched in bodywall muscle
compared to the random list controls. (Bottom) Bodywall muscle and ChIP gene data overlap. Overlap details on the data for three of the bodywall
muscle gene lists as indicated. For each list, the number of overlapping genes in comparison to either the ChIP-seq or ChIP-chip is indicated by Venn
diagrams. The total number of genes in each list is given parenthetically.
doi:10.1371/journal.pone.0015898.g006
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in a previous study [7].
Discussion
Our study was aimed at identifying the binding sites of HLH-1
genome-wide during embryogenesis while addressing two com-
mon problems associated with transcription factor ChIP assays;
limited temporal-spatial patterns of expression and lack of suitable
reagents for immunoprecipitation. These problems were addressed
using two completely different methodologies. In one approach,
we used antibodies directed against HLH-1 in combination with
heat shock induced over expression of HLH-1 in transgenic
animals with ChIP probes hybridized to a genome tiling array
(ChIP-chip). As an alternative, we used an epitope-tagged (GFP)
HLH-1 transgene that was ChIPed with anti-GFP antibodies and
the immunoprecipitated DNA analyzed by next generation
sequencing (ChIP-seq). Using these alternative approaches for
the transcription factor HLH-1 in C. elegans embryos reveals
similar genome-wide profiles for this master myogenic regulator.
Although epitope-tagging has been used previously as a surrogate
to interrogate binding site distributions in multiple systems, the use
of heat shock induced over expression in vivo for such studies is
novel. Despite concerns that over expression might result in a high
rate of false positive binding sites, our data suggests that is not the
case in C. elegans. Our results expand the repertoire of
experimental approaches for ChIP studies to include options
readily engineered in most biological systems.
This study provides valuable insights into HLH-1 biology in C.
elegans. Both ChIP datasets demonstrate that HLH-1 can be
detected just upstream of the TSS of thousands of potential target
genes, that an E-box (CANNTG) is the dominant over-
represented motif in these bound sequence intervals, and the
genes associated with binding sites are enriched in those known to
be expressed in bodywall muscle. The widespread localization of
HLH-1 predominantly to promoter regions is consistent with the
expectation that HLH-1 acts directly to regulate target gene
expression. HLH-1 activity is likely mediated through direct
binding to E-box sequences (CANNTG) in the promoter of target
genes. The symmetry of the top returned E-box motifs is
suggestive of homodimer binding, consistent with the fact that C.
elegans bodywall myogenesis occurs in the absence of the E protein
binding partner for the MRFs typically found in other biological
systems [17]. The strong association of HLH-1 binding sites
upstream of genes known to be expressed in bodywall muscle cells,
including many structural genes, suggests that HLH-1 acts as a
transcriptional activator of these genes. Thus, our data support a
model in which HLH-1 homodimers direct bodywall myogenesis
by directly binding to, and activating, many genes required for the
development and function of muscle.
There were also several surprising aspects of our results from
this study. We did not anticipate the large number of HLH-1
bound intervals and associated genes, up to half of all protein
coding genes in C. elegans in the ChIP-seq data using default
threshold values. Equally important was the lack of evidence for
widespread, ectopic binding of HLH-1 after over expression in the
ChIP-chip data. We found that only a small fraction (,3.5%) of all
possible E-boxes genome wide were identified by either our ChIP-
chip or ChIP-seq (10
26) approaches, arguing for a high degree of
selectivity for HLH-1 binding. A comparison of the HLH-1 ChIP
Table 1. Reporter Gene Construct Details and Results.
ChIP-chip Metrics Evidence for BWM expression
Cosmid Gene Pk Score Pk Rank Peak (bp) E-box Seq Pk Enh
1 hsHLH-1 Reporter Antibody Array Atlas
2 Ref
ZK867.1 syd-9 37.16 2 1864 9 YES No * YES YES YES * [33]
T28B11.1 T28B11.1 35.66 3 1616 11 YES YES * * * YES * [5]
T13H2.4 pqn-65 34.72 6 1136 6 YES No * * * YES * [5]
C07A9.3 tlk-1 34.57 7 2272 4 YES No * * * * * N/A
T05A10.1 sma-9 33.59 13 2333 17 YES No * * * * * N/A
F33A8.3.1 cey-1 6.70 97 2022 6 YES YES * * * YES * [5]
C01G6.1b.1 aqp-2 6.40 122 1890 13 YES No No YES * YES * [34]
T01D1.2a.1 etr-1 5.35 236 2150 13 YES YES No YES * YES * [35]
ZK792.6 let-60 5.09 284 910 5 YES YES * YES * YES * [36]
C38C3.5b.1 unc-60 5.02 300 1343 4 YES YES * * YES YES * [37]
C47E8.7.1 unc-112 4.74 361 1739 8 YES No No YES YES YES * [38,39]
T14A8.1 ric-3 4.69 372 1651 8 YES YES No YES * YES * [40]
B0350.2a.2 unc-44 4.19 515 416 1 No No * YES * YES YES [41]
F45E4.2.1 plp-1 4.19 531 905 4 YES No * YES * YES YES [42]
K04H4.1b emb-9 4.14 548 1551 9 YES No No YES YES YES YES [41,42]
F21H11.3.2 tbx-2 4.00 593 950 5 No No * YES * YES * [43]
F55C7.7a unc-73 3.95 612 680 5 YES No No YES YES YES YES [41,44]
F10E9.6b mig-10 3.70 699 611 8 YES No * YES * YES YES [41]
M88.5b M88.5 3.39 848 867 4 No No * YES * YES YES [41]
F31E3.1 ceh-20 2.88 1069 350 2 YES No No YES * YES * [45]
1Enh – Positive for bodywall muscle enhancer activity.
2Atlas – Reported with bodywall muscle expression in WormAtlas.
doi:10.1371/journal.pone.0015898.t001
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PHA-4, also suggests highly selective binding (1). Although the
peak overlaps between HLH-1 and PHA-4 embryonic datasets
was slightly above random expectations, the associated gene
overlap was at, or far below, random expectations for all pair wise
comparisons. HLH-1 and PHA-4 target genes would not be
expected to overlap in embryos as these two transcription factors
are expressed in mutually exclusive tissues at this stage of
development. Further studies are required to determine if the
binding site specificity we observed is an intrinsic property of
HLH-1 or reflects additional constraints, including required
cooperativity with other factors or the limited accessibility to
potential binding sites in the context of general or tissue-specific
chromatin organization.
We were also surprised to find that neither of the ChIP methods
identified a majority of the genes defined previously by various
groups cataloging the bodywall muscle transcriptome. The best
observed overlap (45%) was between the ChIP-seq (10
26) and the
297 WormAtlas bodywall muscle expression gene list. The
inability to identify all bodywall muscle genes by mixed stage
embryo ChIP technology is not completely unexpected because
some bodywall muscle genes may be activated late in embryo-
genesis or post-embryonically. However, the discordance between
the ChIP data and bodywall muscle transcriptome profiles also
highlights the inherent flaws in experimental manipulation,
current technologies employed for gene expression and ChIP
studies, and bioinformatic treatment of the resulting data. At the
level of gene expression, each of the several attempts to define the
bodywall muscle transcriptome in C. elegans has generated a gene
list, yet there is limited consensus among these. These differences
arise due to many factors, including methodological efficiencies,
life stage variability, and the use of various experimental platforms
to assay expression. At the ChIP level, our results similarly
highlight the variability associated with experimental and platform
differences. For example, our ability to validate ChIP-seq peaks
not detected by ChIP-chip, using the ChIP-chip reagents and
methods demonstrates that our ChIP-chip data is under
representing the HLH-1 binding sites. One likely explanation of
this under representation is the limited dynamic range of chip
hybridizations that makes the discrimination of signal and
background more difficult compared to the more quantitative
next generation sequencing approach. In addition, our ChIP-chip
peak calls required consensus between three biological replicates, a
stringency that may have eliminated true positives. The identifi-
cation and validation of ChIP-chip HLH-1 binding sites that were
not detected by ChIP-seq are more difficult to explain. Clearly, no
single approach captures a clear and complete view of transcrip-
tional systems suggesting a combination of approaches is likely
needed to more fully understand the relationship of transcription
factor DNA binding and gene expression.
Our inability to validate many HLH-1 bound sequences with in
vivo assays for enhancer activity, even in the presence of heat shock
induced over expression of HLH-1, was also unexpected. Although
such reporter assays are fraught with caveats, they frequently can be
successfully used to demonstrate enhancer function. It seems likely
that many sites that bind HLH-1 alone in vivo may not be
associated with transcriptional activity. Such sites may never be
transcriptionally active, may require additional factors to cooperate
for activation through associated cis-acting sequences, or may be
sites of transcriptional repression. Regardless, the large number of
binding sites makes the correlation of ChIP data with bodywall
muscle transcriptomes an imperfect science, demonstrating clear
overlaps between the datasets, but at levels that are insufficient to
describe the network with any confidence.
A recent study of genome binding sites of the mammalian
homolog of HLH-1, MyoD, found results very comparable to ours
[27]. That study suggested that mouse MyoD binds approximately
60,000 sites on the autosomes, is associated with between 41–74%
of all protein coding genes, is positively correlated with genes
expressed during myogenesis, and that MyoD binding sites often
fail in enhancer activity assays in tissue culture. These remarkably
similar observations for MyoD in the mouse system to our results
in C. elegans for HLH-1 suggest evolutionary conservation in the
roles for this master regulatory transcription factor, both in
activation of target muscle genes and in as yet to be determined
functions genome-wide.
Our results suggest, as in mammals, that many of the binding
sites for HLH-1 in C. elegans may be functionally inert or play a role
not directly linked to transcriptional activation, such as modifying
or maintaining chromosomal architecture necessary for a
committed muscle cell fate. These alternate functions may underlie
the non-random distribution of HLH-1 binding sites on the
chromosomes, including a vast over-representation of the ChIP
overlapping set on the X chromosome. The high number of
genome-wide binding sites for HLH-1/MyoD presents an
unanticipated challenge for the field in interpreting the increasing
volumes of transcription factor ChIP data becoming available. An
unexpectedly large number of binding sites have also been
observed for several transcription factors in Drosophila, suggesting
this is a general feature of these factors [28,29,30]. Clearly, the
function of transcription factors, as well as the predictive power
with respect to transcriptional activation or repression, will require
the combination of profiles for multiple factors and chromatin
modifications to be fully understood.
Methods
C. elegans strains
The following C. elegans strains were used: wild type (N2); the
heat shock promoter driven hlh-1 strains KM472 and KM267 [5];
a derivative of KM267 in which we introduced the selectable
transformation mutation unc-119 (ed3) for testing enhancer
reporter genes in the presence of over expressed HLH-1.
Generating transgenic lines
A GFP-tagged hlh-1 coding region in the context of a fosmid
clone was introduced into animals by biolistic transformation using
the unc-119 selection marker, as previously described [31]. Stably
segregating lines were selected over four generations prior to use in
ChIP-seq experiments. Transgenic strains for assaying expression
were generated using standard injection techniques with 10–
100 ug of test plasmid and 50 ug of the selectable dominant rol-6
plasmid pRF4. At least two stable transgenic lines were generated
for each construct and expression in both adult and embryonic
bodywall muscle lineages was determined. The 20 fragments
corresponding to the selected peak sequences (Table 1) were
amplified using C. elegans genomic DNA as template. The
amplified fragments were inserted into the PstI site of the L3136
plasmid upstream of the basic promoter reporter construct Pmyo2-
gfp-lacZ to make a series of reporter constructs. All reporter gene
construct sequences were confirmed by DNA sequencing. PCR
primers for all reporter constructs are listed in Table S4.
Chromatin Immunoprecipitation (ChIP) Assays
The ChIP assay was conducted as described previously [7]. The
hsp::hlh-1 transgenic strain KM267 was used in this assay. For the
ChIP-chip assay, ChIP DNA from heat shock hsp::hlh-1 transgenic
lines after cross-linking and immunoprecipitation with antibody
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genome amplification kit (Sigma-Aldrich) according to the
protocols provided by Nimblegen. Immunoprecipitated DNA
with chicken anti-HLH-1 (experimental) or pre-immune chicken
serum (control) samples was prepared in biological triplicates.
Nimblegen C. elegans tiling array contain 385,000 oligonucleotides
covering the C. elegans genome at a resolution of 50 bp with 36 bp
gaps between probes. ChIP-chip hybridization and scanning were
done by Nimblegen. ChIP-seq assays were conducted using the
modENCODE pipeline as previously described [1].
Data analysis
Quantile normalization, peak detection, gene annotation, peak
distribution was done using the CARPET tiling analysis software
package [8]. HLH-1 bound peaks and interval sequences were
identified using the following parameters in the notator function:
analysis type, p-value; percentile value, 0.95; -log p-value cutoff,
13; minimal number of probes, 5; max distance between two
probes, 100; min distance between two peaks, 200; window length,
500; promoter definition (bp), 22000; annotation priority, gene.
We employed two different software packages to compare the
overlap of peak calls between datasets, with very similar results
from each. The CARPET package [8] Com&Easy function was
used with the following settings:parameter set: Principal table,
variable p-value cut off for the ChIP-seq peaks; Secondary table,
ChIP-chip peaks; Analysis type, common; Coordinate common,
Principal Table. Alternatively, we used Galaxy software [9] to
compare peak calls. Galaxy was used to generate the data shown
in Table S2. MDscan [14] was used for the Motif search.
Confirmation of ChIP-chip binding regions using qPCR
Primers were designed for HLH-1 ChIP enriched genomic
DNA regions using Primer3 (http://frodo.wi.mit.edu/primer3/)
[32]. Real-time quantitative PCR (qPCR) was performed on the
ABI 7900HT sequence detection system using the Power SYBR
Green PCR master mix (Applied Biosystems). Primers and
associated genes for the qPCR amplicons are listed in Table S4.
Supporting Information
Figure S1 Genome browser view comparison of ChIP data. An
Integrated Genome Browser (IGB) view of the ChIP data for a
1,000 kb region of LGII of C. elegans shows the peak intervals at
top (blue boxes) relative to gene coding regions on the plus and
minus coding strands below (green boxes). ChIP-seq intervals
using both default and e
26 thresholds are shown for comparison to
the ChIP-chip intervals. Note the similarity in patterns among
ChIP datasets with the ChIP-chip intervals constituting an
increasingly smaller subset as the ChIP-seq data threshold is
reduced.
(TIF)
Figure S2 The HLH-1 bound interval upstream of etr-1 drives
bodywall muscle expression. The 2,150 bp interval identified by
HLH-1 ChIP-chip and ChIP-seq methods was fused to a reporter
gene used to assay bodywall muscle activity and introduced into a
wild-type background by transgenesis. This genomic fragment was
sufficient to drive bodywall muscle expression of the reporter in
embryos, larvae, and adults.
(TIF)
Figure S3 Heat shock induction of HLH-1. Total embryonic
lysates from wild type animals (Cntrl) or strains harboring a heat
shock inducible hlh-1 cDNA transgene (paired lanes 1–7) were
assayed by Western blot probed with chicken anti-HLH-1
antibody. Lysates were prepared from embryos of gravid adults
three hours after mock (2) or heat shock treatment (+) and equal
amounts of total protein was loaded in each lane. All transgenic
strains show strong induction of HLH-1 in response to heat shock.
M is molecular size marker. Samples 1 & 2 are the heat shock hlh-1
strains, KM267 & KM472, respectively, which have been
previously characterized (Lei et al., 2009). Samples 3–7 are
embryo extracts from strains harboring both the heat shock hlh-1
transgene and reporter genes of amplicons associated with the
following genes: sample 3: aqp-2, sample 4: etr-1, sample 5: ric-3,
sample 6: ceh-20, sample 7: emb-9. Arrows indicate full-length
HLH-1.
(TIF)
Table S1 ChiP-chip peak call data.
(XLS)
Table S2 Gene list calls for ChiP-chip, ChIP-seq, and the
overlap of each method.
(XLS)
Table S3 ChiP-seq (e
26) peak call data.
(XLS)
Table S4 Primer sequence information.
(XLS)
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